https://orcid.org/0000-0002-1730-9691
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mimi Choon-Quinones, Tamás Zelei, Bertalan Németh, Manna Tóth, Xiao Yang Jia, Mike Barnett, Paul Keown, Brian Durie, Jean-Luc Harousseau, Dirk Hose & Zoltán Kaló. (2023) Systematic literature review of health economic models developed for multiple myeloma to support future analyses. Journal of Medical Economics 26:1, pages 110-119.
Read now
Read now
Peter Feng Wang, Christopher W. Yee, Boris Gorsh, Miriam L. Zichlin, Prani Paka, Rachel H. Bhak, Natalie Boytsov, Anamika Khanal, Ahmed Noman, Maral DerSarkissian, Shannon Ferrante & Mei Sheng Duh. (2023) Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study. Leukemia & Lymphoma 64:2, pages 398-406.
Read now
Read now
Articles from other publishers (17)
Joseph YangNatalie BoytsovJosh J. CarlsonDouglas Barthold. (2023) Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis. Journal of Managed Care & Specialty Pharmacy 29:8, pages 917-926.
Crossref
Crossref
Xavier Leleu, Boris Gorsh, Antoine Bessou, Prani Paka, Julie De Nascimento, Xavier Colin, Suzanne Landi & Peter Feng Wang. (2023) Survival outcomes for patients with multiple myeloma in France: A retrospective cohort study using the Système National des Données de Santé national healthcare database. European Journal of Haematology 111:1, pages 125-134.
Crossref
Crossref
Fen Saj, Yadav Nisha, Prasanth Ganesan, Smita Kayal, Rakhee Kar, Dhanapathi Halanaik & Biswajit Dubashi. (2023) Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study. Blood Cancer Journal 13:1.
Crossref
Crossref
Miguel Esperança-Martins, Diogo Roque, Tiago Barroso, André Abrunhosa-Branquinho, Diogo Belo, Nuno Simas & Luis Costa. (2023) Multidisciplinary Approach to Spinal Metastases and Metastatic Spinal Cord Compression—A New Integrative Flowchart for Patient Management. Cancers 15:6, pages 1796.
Crossref
Crossref
Giada Bianchi,Matthew Ho,Kenneth C. Anderson. 2023. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies. Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies
313
330
.
Rolf Snijders, Linda Brom, Maurice Theunissen & Marieke van den Beuken-van Everdingen. (2023) Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis. Cancers 15:3, pages 591.
Crossref
Crossref
Helan Kurian, Suja Abraham, Arpith Antony, Jeeva Ann Jiju & Timy Thomas. (2023) Multiple myeloma: Unveiling the survival data with different lines of treatments. Journal of Cancer Research and Therapeutics 19:3, pages 720-724.
Crossref
Crossref
Sundar Jagannath, Nedra Joseph, Jinghua He, Concetta Crivera, Alex Z. Fu, Ashraf Garrett & Nina Shah. (2022) Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States. Oncology and Therapy 10:2, pages 411-420.
Crossref
Crossref
Abdallah Y. Naser, Richard Ofori-Asenso, Safaa Al Awawdeh, Sami Qadus, Hassan Alwafi & Danny Liew. (2022) Real World Adherence to and Persistence With Oral Oncolytics in Multiple Myeloma: A Systematic Review and Meta-analysis. Clinical Lymphoma Myeloma and Leukemia 22:10, pages 760-773.
Crossref
Crossref
Hira Mian, Donna Reece, Esther Masih-Khan, Arleigh McCurdy, Moustafa Kardjadj, Victor H Jimenez-Zepeda, Kevin Song, Martha Louzada, Richard LeBlanc, Michael Sebag, Darrell White, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Engin Gul & Christopher P. Venner. (2022) Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database. Clinical Lymphoma Myeloma and Leukemia 22:8, pages 608-617.
Crossref
Crossref
Nina Shah, Ali Mojebi, Dieter Ayers, Shannon Cope, Sujith Dhanasiri, Faith E Davies, Parameswaran Hari, Payal Patel, Kristen Hege & Devender Dhanda. (2022) Indirect treatment comparison of idecabtagene vicleucel versus conventional care in triple-class exposed multiple myeloma. Journal of Comparative Effectiveness Research 11:10, pages 737-749.
Crossref
Crossref
Reeder M. Robinson, Ashton P. Basar, Leticia Reyes, Ravyn M. Duncan, Hong Li & Nathan G. Dolloff. (2022) PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma. Cancer Chemotherapy and Pharmacology 89:5, pages 643-653.
Crossref
Crossref
Shebli Atrash, Evelyn M. Flahavan, Tao Xu, Esprit Ma, Sudeep Karve, Wan-Jen Hong, Gilbert Jirau-Lucca, Michael Nixon & Sikander Ailawadhi. (2022) Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis. Blood Cancer Journal 12:3.
Crossref
Crossref
Aneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik, Marcin Mazurek, Sylwia Chocholska, Martyna Podgajna, Michał Szczyrek, Iwona Homa-Mlak, Teresa Małecka-Massalska & Marek Hus. (2022) Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma. Cells 11:4, pages 752.
Crossref
Crossref
Leah M. Alabanza, Ying Xiong, Bang Vu, Brian Webster, Darong Wu, Peirong Hu, Zhongyu Zhu, Boro Dropulic, Pradyot Dash & Dina Schneider. (2022) Armored BCMA CAR T Cells Eliminate Multiple Myeloma and Are Resistant to the Suppressive Effects of TGF-β. Frontiers in Immunology 13.
Crossref
Crossref
Rahul Banerjee, Mimi Lo & Thomas G MartinIIIIII. (2021) Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma. Future Oncology 17:35, pages 4849-4860.
Crossref
Crossref
Kamal Chamoun, Amin Firoozmand, Paolo Caimi, Pingfu Fu, Shufen Cao, Folashade Otegbeye, Leland Metheny, Seema Patel, Stanton L. Gerson, Kirsten Boughan, Marcos De Lima & Ehsan Malek. (2021) Socioeconomic Factors and Survival of Multiple Myeloma Patients. Cancers 13:4, pages 590.
Crossref
Crossref